Related Experiment Video

Updated: Jun 22, 2026

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis

Liren Liu1, Sharrell Lee, Jianxuan Zhang

  • 1Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.

Molecular Cell
|June 2, 2009
PubMed

Insights

The CUL4A ubiquitin ligase limits cellular DNA repair capacity by degrading key repair proteins. Inhibiting CUL4A enhances DNA repair and resistance to UV-induced skin cancer.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Cellular DNA repair is essential for preventing mutations and cancer.
  • The mechanisms limiting DNA repair capacity are not well understood.
  • DNA damage response pathways, including nucleotide excision repair (NER) and checkpoints, are critical.

Purpose of the Study:

  • To investigate the role of CUL4A ubiquitin ligase in regulating cellular DNA repair capacity.
  • To identify the mechanisms by which CUL4A establishes DNA repair thresholds.
  • To evaluate the therapeutic potential of targeting CUL4A for cancer prevention.

Main Methods:

  • Generated Cul4a conditional knockout mice for skin-specific gene ablation.
  • Assessed DNA repair proficiency and resistance to UV-induced carcinogenesis.
  • Investigated the degradation of DNA damage sensors (DDB2, XPC) and checkpoint effector (p21/CIP1/WAF1) by CUL4A.

Main Results:

  • CUL4A ubiquitin ligase restricts cellular DNA repair capacity.
  • CUL4A orchestrates NER and G1/S checkpoint by degrading DDB2, XPC, and p21/CIP1/WAF1.
  • Skin-specific Cul4a ablation in mice significantly increased resistance to UV-induced skin carcinogenesis.
  • Wild-type cells do not operate at maximum DNA repair potential.

Conclusions:

  • CUL4A plays a critical role in establishing the cellular DNA repair threshold.
  • Pharmacological inhibition of CUL4A may enhance cellular repair proficiency.
  • Targeting CUL4A presents a potential strategy for augmenting DNA repair and preventing UV-induced skin cancer.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Related Concept Videos

Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations01:39

Mutations

Overview
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...